The results of the assessment of tumor immune cell populations in tumors showed that anti PD-1 treatment slightly enriched CD8+ and CD4+ T cells, but it did not affect the infiltration of Tregs, MΦ, and DC. The gene discussed is CD8A; the disease is neoplasm.